Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per AUTORE
BOCCADORO M
Collezione AOU Città della Salute di Torino

Items : 286

A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma. in Future oncology (London, England) / Future Oncol. 2024 Sep 17:1-21. doi: 10.1080/14796694.2024.2394323.

2024
AOU Città della Salute di Torino

Sonneveld P; Dimopoulos MA; Boccadoro M; Quach H; Ho PJ; Beksac M; Hulin C; Antonioli E; Leleu X; Mangiacavalli S; Perrot A; Cavo M; Belotti A; Broijl A; Gay F; Mina R; van de Donk NWCJ; Katodritou E; Schjesvold F; Balari AS; Rosiñol L; Delforge M; Roeloffzen W; Silzle T; Vangsted A; Einsele H; Spencer A; Hajek R; Jurczyszyn A; et alii...

A prospective, multicenter study on hematopoietic stemcell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents. in Haematologica / Haematologica. 2024 May 1;109(5):1525-1534. doi: 10.3324/haematol.2023.284023.

2024
AOU Città della Salute di Torino

Corradini P; Milone G; Mancuso K; Bruno B; Fazio F; Anaclerico B; Cangialosi C; Nozzoli C; Olivieri A; Rota-Scalabrini D; Cupelli L; Tosi P; Floris R; Ballanti S; Lemoli RM; Lisi C; Curci P; Mengarelli A; Spadaro A; Bertuglia G; Bongarzoni V; Saccardi R; Boccadoro M; Bonello F; Petrucci MT; Mina R;

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients. in Leukemia / Leukemia. 2024 Mar;38(3):640-647. doi: 10.1038/s41375-023-02105-6. Epub 2023 Dec 7.

2024
AOU Città della Salute di Torino

Goldschmidt H; Sonneveld P; Weisel KC; Cavo M; Hillengass J; Dimopoulos MA; Boccadoro M; Scheid C; von Metzler I; Graeven U; Müller-Tidow C; Hänel M; Besemer B; Fenk R; van der Holt B; Reimer P; Dürig J; Blau IW; Beksac M; Brossart P; Mancuso K; Zweegman S; Raab MS; Munder M; Pantani L; Salwender HJ; Mai EK; Hielscher T; Bertsch U; et alii...

Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells. in Blood cancer journal / Blood Cancer J. 2024 Jun 7;14(1):94. doi: 10.1038/s41408-024-01075-x.

2024
AOU Alessandria
AOU Città della Salute di Torino

Gay F; Musto P; Boccadoro M; Calogero RA; Bruno B; Stefanoni P; Zamagni E; Palmieri S; Monaco F; Liberati AM; Annibali O; Galieni P; Garzia M; Olivero M; Rogers J; Ruggeri M; Pescosta N; Pisani F; Bertamini L; Arigoni M; De Sabbata G; Pietrantuono G; Pascarella A; Tosi P; Belotti A; D'Agostino M; Rota-Scalabrini D;

Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. in EJHaem / EJHaem. 2024 Apr 30;5(3):485-493. doi: 10.1002/jha2.907. eCollection 2024 Jun.

2024
AOU Città della Salute di Torino

Morè S; Boccadoro M; Offidani M; Derudas D; Gamberi B; Musto P; De Stefano V; Antonioli E; Conticello C; Renzo ND; Zambello R; Belotti A; Bringhen S; Musso M; Tacchetti P; Corvatta L; Della Pepa R; Fazio F; Petrucci MT; Piciocchi A;

Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma. in Blood cancer journal / Blood Cancer J. 2024 Jul 19;14(1):117. doi: 10.1038/s41408-024-01096-6.

2024
AOU Città della Salute di Torino

Larocca A; Massaia M; Maura F; Bruno B; Boccadoro M; Bolli N; Landgren O; Coffey D; Corradini P; Papadimitriou M; Diamond B; Oliva S; Genuardi E; Saraci E; D'Agostino M; Bertuglia G; Giannotta C; Ziccheddu B;

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. in The New England journal of medicine / N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12.

2024
AOU Città della Salute di Torino

Moreau P; Bladé J; Rodriguez-Otero P; Carson R; de Boer CJ; Sitthi-Amorn A; Vanquickelberghe V; van Brummelen EMJ; Vieyra D; Wang J; Liu Y; Ahmadi T; Lonergan S; Jurczyszyn A; Hajek R; Spencer A; Einsele H; Vangsted A; Silzle T; Roeloffzen W; Delforge M; Rosiñol L; Sureda Balari A; Schjesvold F; Katodritou E; van de Donk NWCJ; Nijhof IS; Mina R; Gay F; et alii...

Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2023 Oct;10(10):e813-e824. doi: 10.1016/S2352-3026(23)00218-1.

2023
AOU Città della Salute di Torino

Sonneveld P; Carson R; Tran N; Liu W; Wang J; Kosh M; Kampfenkel T; Einsele H; Orfanidis I; Mateos MV; Oriol A; Bila J; Symeonidis A; Baldini L; Katodritou E; Moreau P; Beksac M; Boccadoro M; Delimpasi S; Terpos E; Dimopoulos MA;

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study. in The Lancet. Oncology / Lancet Oncol. 2023 Oct;24(10):1119-1133. doi: 10.1016/S1470-2045(23)00405-9. Epub 2023 Sep 14.

2023
AO Cuneo
AOU Città della Salute di Torino

Musto P; Boccadoro M; Gay F; Sonneveld P; Vangsted AJ; Benjamin R; Hájek R; Silkjaer T; Caers J; Zweegman S; Mancuso K; Razawy W; Tacchetti P; Offidani M; Grasso M; Giaccone L; van der Velden VHJ; Pour L; Lund T; Gadisseur A; Pietrantuono G; Roeloffzen WWH; Broijl A; Schjesvold F; Wu KL; van der Holt B; Minnema MC; van de Donk NWCJ;

Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network. in The Lancet. Oncology / Lancet Oncol. 2023 Jun;24(6):e255-e269. doi: 10.1016/S1470-2045(23)00159-6.

2023
AOU Città della Salute di Torino

Weisel K; Cook G; Engelhardt M; Zweegman S; Musto P; Driessen C; Caers J; Einsele H; Mina R; Gay F; Yong K; San-Miguel J; Rodriguez-Otero P; Delforge M; Dimopoulos MA; Mateos MV; Moreau P; van de Donk N; Terpos E; Ludwig H; Broijl A; Beksac M; Bila J; Schjesvold F; Cavo M; Hajek R; Touzeau C; Boccadoro M; Sonneveld P; et alii...

Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2023 Jun;37(6):1175-1185. doi: 10.1038/s41375-023-01920-1. Epub 2023 May 4.

2023
AOU Città della Salute di Torino

Sonneveld P; Ludwig H; Dimopoulos MA; San-Miguel J; Boccadoro M; Einsele H; Moreau P; Hajek R; Zweegman S; Cerchione C; Schjesvold F; Driessen C; Vangsted AJ; Ntanasis-Stathopoulos I; van de Donk NWCJ; Cook G; Gay F; Delforge M; Engelhardt M; Musto P; Terpos E;

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102017. doi: 10.1016/j.eclinm.2023.102017. eCollection 2023 Jun.

2023
AO Cuneo
AOU Città della Salute di Torino

Fanti S; Tacchetti P; Zucchetta P; Pascarella A; Villanova T; De Cicco G; Patriarca F; Fioritoni F; Priola C; Sgherza N; Grasso M; Versari A; Bertamini L; Gamberi B; Albano D; Zambello R; Racca M; Galli M; Belotti A; D'Agostino M; Rota-Scalabrini D; Capra A; Gay F; Oliva S; Zamagni E; Mancuso K; Barbato S; Boccadoro M; Musto P; et alii...

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 9;60:102016. doi: 10.1016/j.eclinm.2023.102016. eCollection 2023 Jun.

2023
AOU Città della Salute di Torino

Oliva S; Genuardi E; Paris L; D'Agostino M; Rogers J; Rota-Scalabrini D; Jacob AP; Patriarca F; Luppi M; Bertazzoni P; Velluti C; Capra A; Saraci E; Rossi M; Allegra A; Mina R; Gentile M; Kirsch IR; Belotti A; Cavo M; Bruno B; Musto P; Boccadoro M; Zamagni E; Gay F;

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial. in The Lancet. Oncology / Lancet Oncol. 2023 Jan;24(1):64-76. doi: 10.1016/S1470-2045(22)00693-3. Epub 2022 Dec 14.

2023
AOU Città della Salute di Torino
AO Cuneo

Boccadoro M; Gay F; Ballanti S; Belotti A; Giuliani N; De Rosa L; Gozzetti A; Cellini C; Bertamini L; Grasso M; Zamagni E; Fioritoni F; Cea M; Pescosta N; Vincelli ID; Ronconi S; Pavone V; Capra A; Oddolo D; de Fabritiis P; Palmas A; Mina R; Paris L; Aquino S; Gamberi B; Rota-Scalabrini D; Musto P;

CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ?66 YEARS in HemaSphere

2023
AOU Città della Salute di Torino

Musto P; Minnema MC; Roeloffzen WWH; Capra A; Van Der Holt B; Juul Vangsted A; Broyl A; Schjesvold F; Lund T; Silkjaer T; Benjamin R; Grasso M; Lung Wu K; Caers J; Cavo M; Hájek R; Bruno B; Gadisseur A; Pietrantuono G; Offidani M; Pour L; Sonneveld P; Boccadoro M; Van De Donk N;

BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REALLIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL in HemaSphere

2023
AOU Città della Salute di Torino

Larocca A; D'Agostino M; Giuliani N; Antonioli E; Zambello R; Ronconi S; Vincelli ID; Ciceri F; Falcone AP; Michieli M; Cattel F; Capra A; Grasso M; Cafro AM; Bonello F; Floris R; Offidani M; Sciorsi E; Pietrantuono G; Curci P; Patriarca F; Cavo M; Mangiacavalli S; Benevolo G; Evangelista A; Ciccone G; Boccadoro M; Bruno B; Bringhen S; et alii...

CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ?66 YEARS in HemaSphere

2023
AOU Città della Salute di Torino

CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS in HemaSphere

2023
AOU Città della Salute di Torino

Van De Donk N; Minnema MC; Van Der Holt B; Schjesvold F; Wu KL; Capra A; Broyl A; Roeloffzen WWH; Gadisseur APA; Pietrantuono G; Pour L; Van Der Velden V; Lund T; Offidani M; Grasso M; Giaccone L; Cavo M; Silkjaer T; Caers J; Zweegman S; Hajek R; Benjamin R; Vangsted A; Boccadoro M; Gay F; Sonneveld P; Musto P;

Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing in eClinicalMedicine

2023
AOU Città della Salute di Torino

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6.

2022
AOU Città della Salute di Torino
AOU Alessandria

Gay F; Boccadoro M; Musto P; Tacchetti P; Belotti A; Fazio F; Zambello R; Luppi M; Monaco F; Ledda A; Gentile M; De Sabbata G; Pietrantuono G; Pascarella A; Tosi P; Curci P; Gilestro M; Capra A; Galieni P; Liberati AM; Pisani F; Annibali O; Palmieri S; Corradini P; Morè S; Rota-Scalabrini D; Paris L; Bertamini L; Oliva S; et alii...

Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Sep;33(9):988. doi: 10.1016/j.annonc.2022.05.004. Epub 2022 Jul 6.

2022
AOU Città della Salute di Torino

San-Miguel J; Sonneveld P; Mey U; Boccadoro M; Einsele H; Facon T; Goldschmidt H; Schjesvold F; Cavo M; Hájek R; Delforge M; Cook G; Zweegman S; Mateos MV; Terpos E; Moreau P; Dimopoulos MA;

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2022 Oct 10;40(29):3406-3418. doi: 10.1200/JCO.21.02614. Epub 2022 May 23.

2022
AOU Città della Salute di Torino

San-Miguel JF; Sonneveld P; Boccadoro M; Larocca A; Cook G; Hernández Rivas JM; Kaiser MF; Goldschmidt H; Cavo M; Zweegman S; Gay F; Dürig J; Capra A; Mai EK; Bonello F; Castellani G; van der Holt B; Bladé Creixenti J; Salwender H; Rocchi S; Jackson G; van de Donk NWCJ; Dall'Olio D; Mateos MV; Zamagni E; Waage A; Bertsch U; Wester R; Lahuerta JJ; et alii...

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials. in Hematological oncology / Hematol Oncol. 2022 Oct;40(4):704-715. doi: 10.1002/hon.3031. Epub 2022 Jun 1.

2022
AOU Città della Salute di Torino

Gentile M; Morabito F; Neri A; Cavo M; Boccadoro M; Musto P; Offidani M; Petrucci MT; Palmieri S; De Stefano V; Di Raimondo F; Patriarca F; Zamagni E; Bringhen S; Consoli U; Frigeri F; Tripepi G; Pompa A; Gamberi B; Gagliardi A; Gangemi D; Ballanti S; Martino M; Stocchi R; Cupelli L; Bonalumi A; Sgherza N; Botta C; Vincelli D; et alii...

Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma. in HemaSphere / Hemasphere. 2022 Sep 30;6(10):e786. doi: 10.1097/HS9.0000000000000786. eCollection 2022 Oct.

2022
AOU Città della Salute di Torino

Ypma P; Boccadoro M; Minnema MC; Zojer N; Teresa Petrucci M; Hajek R; Bos G; Droogendijk J; Patriarca F; Wu K; Corradini P; Croockewit S; Pour L; Broijl A; Troia R; Nasserinejad K; Cavo M; Zweegman S; Sonneveld P;

Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. in Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis / Amyloid. 2022 Mar;29(1):1-7. doi: 10.1080/13506129.2021.2002841. Epub 2021 Nov 16.

2022
AOU Città della Salute di Torino

Palladini G; Wechalekar A; Landau H; Mollee P; Kastritis E; Hegenbart U; Boccadoro M; Gertz M; Sanchorawala V;

Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients. in European journal of haematology / Eur J Haematol. 2022 Mar;108(3):178-189. doi: 10.1111/ejh.13723. Epub 2021 Nov 9.

2022
AOU Città della Salute di Torino

Boccadoro M; Cavo M; Gentile M; Di Renzo N; Di Raimondo F; Neri A; Offidani M; Teresa Petrucci M; De Stefano V; Musso M; Musto P; Ria R; Catalano L; Tacchetti P; Mele G; Donatella Vincelli I; Antonia Martino E; Vigna E; Botta C; Bruzzese A; Mele A; Pantani L; Rocchi S; Garibaldi B; Cascavilla N; Ballanti S; Tripepi G; Frigeri F; Pia Falcone A; et alii...

Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Jan;33(1):117. doi: 10.1016/j.annonc.2021.10.001. Epub 2021 Nov 29.

2022
AOU Città della Salute di Torino

Mey U; Sonneveld P; San-Miguel J; Boccadoro M; Facon T; Cavo M; Goldschmidt H; Hájek R; Schjesvold F; Cook G; Delforge M; Zweegman S; Mateos MV; Dimopoulos MA; Terpos E; Moreau P; Einsele H;

Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant. in Bone marrow transplantation / Bone Marrow Transplant. 2022 Feb;57(2):312-314. doi: 10.1038/s41409-021-01541-1. Epub 2021 Nov 30.

2022
AOU Città della Salute di Torino

Bruno B; Boccadoro M; Evangelista A; Tassi V; Francisci T; Leone S; Cattel F; Bringhen S; Cavallo F; Ferrero D; Massaia M; Lia G; Omedè P; Redoglia V; Cerrano M; Scaldaferri M; Londono JS; Giaccone L; Brunello L;

Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials. in Frontiers in oncology / Front Oncol. 2022 Jul 18;12:890376. doi: 10.3389/fonc.2022.890376. eCollection 2022.

2022
AOU Città della Salute di Torino

Petrucci MT; Offidani M; Gentile M; Neri A; Cavo M; Boccadoro M; Di Raimondo F; Musso M; De Stefano V; Musto P; Gamberi B; Curci P; Mimmi S; Iaccino E; Rizzello I; Barone M; Farina G; Reddiconto G; Cangialosi C; Falcone AP; Frigeri F; Tripepi G; Ballanti S; Cascavilla N; Garibaldi B; Rocchi S; Pantani L; Mele A; Botta C; et alii...

Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network. in Cancer / Cancer. 2021 Sep 15;127(18):3413-3421. doi: 10.1002/cncr.33647. Epub 2021 Jun 28.

2021
AOU Città della Salute di Torino

Gramatzki M; Boccadoro M; Sonneveld P; Einsele H; Straka C; Palumbo A; Corradini P; Gentili S; Wäsch R; Schub N; Spada S; Pönisch W; Aquino S; Patriarca F; Montefusco V; Salvini M; Engelhardt M; Offidani M; Günther A; Gay F;

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US. in Annals of hematology / Ann Hematol. 2021 Sep;100(9):2325-2337. doi: 10.1007/s00277-021-04534-8. Epub 2021 May 10.

2021
AOU Città della Salute di Torino

Zonder J; Boccadoro M; Thompson M; Weisel K; Lee HC; Berdeja J; Leleu X; Huang H; Stull DM; Cherepanov D; Terpos E; Hajek R; Romanus D; Palumbo A; Abonour R; Usmani S; Morgan G; Costello C; Rifkin R; Davies F; Blazer M; Chari A; Cook G; Puig N; Vela-Ojeda J; Farrelly E; Raju A;

Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Nov 10;39(32):3613-3622. doi: 10.1200/JCO.21.01045. Epub 2021 Sep 14.

2021
AOU Città della Salute di Torino

Palumbo GA; Offidani M; van de Donk NWCJ; Minnema MC; Waage A; Hveding C; Pour L; Croockewit A; Broijl A; Driessen C; Levin MD; Bos G; Ypma PF; Wu K; van de Velden V; Oliva S; Troia R; Gulbrandsen N; Cornelisse P; Gregersen H; Morelli A; De Rosa L; Cafro A; Gay F; Pantani L; Dozza L; Wester R; Hajek R; Zamagni E; et alii...

2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde. in Haematologica / Haematologica. 2021 Nov 1;106(11):2799-2812. doi: 10.3324/haematol.2021.278519.

2021
AOU Città della Salute di Torino

Miguel JS; Mateos MV; Sonneveld P; Barosi G; Boccadoro M; Ludwig H; Einsele H; Dimopoulos M; Cavo M; Zweegman S; Vangsted AJ; Zamagni E; Hajek R; Goldschmidt H; Gay F; De Larrea CF; Broijl A; Terpos E; Van de Donk N; Kaiser M; Bolli N; Caers J; Engelhardt M; Musto P;

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.

2021
AOU Città della Salute di Torino

Richardson PG; Dimopoulos MA; Rajkumar SV; Mateos MV; Cook G; Nahi H; Sezer O; Harrison S; Holstein S; Zweegman S; Usmani SZ; Boccadoro M; Kaiser M; Costa LJ; Beksac M; Gay F; Munshi NC; Laubach J; Goldschmidt H; Harousseau JL; Dytfeld D; Mellqvist UH; Chng WJ; Hou J; Bergsagel PL; Riva E; Bladé J; Leleu X; Driessen C; et alii...

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(†). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3.

2021
AOU Città della Salute di Torino

Mey U; Sonneveld P; San-Miguel J; Boccadoro M; Terpos E; Mateos MV; Einsele H; Cavo M; Goldschmidt H; Schjesvold F; Cook G; Delforge M; Hájek R; Moreau P; Facon T; Dimopoulos MA; Zweegman S;

Targeting HIF-1? Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL. in Cancers / Cancers (Basel). 2021 Jun 9;13(12):2883. doi: 10.3390/cancers13122883.

2021
AOU Città della Salute di Torino

Godio L; Voena C; Perutelli F; Boccadoro M; Boccellato E; Salvetti C; Jones R; Kopecka J; Todaro M; Riganti C; Griggio V; Vitale C; Coscia M;

Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma. in Blood / Blood. 2021 Jun 3;137(22):3027-3036. doi: 10.1182/blood.2020009507.

2021
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Tacchetti P; Boccadoro M; Bringhen S; Corradini P; Patriarca F; Caravita di Toritto T; Pompa A; Monaco F; Cellini C; Giuliani N; Bernardini A; Rota-Scalabrini D; Antonioli E; Marasca R; Galli M; Tosi P; Benevolo G; Cascavilla N; Capra A; Offidani M; Gaidano G; D'Agostino M; Bonello F; Larocca A;

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial. in Blood cancer journal / Blood Cancer J. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0.

2021
AOU Città della Salute di Torino

Sonneveld P; Boccadoro M; van der Velden VHJ; Cavo M; Omedé P; Gay F; Galli M; Hajek R; Ribolla R; Gilestro M; Offidani M; Brandt-Hagens C; Jugooa R; Vsianska P; Villanova T; Petrucci MT; Troia R; van der Holt B; Capra A; Pantani L; Rihova L; D'Agostino M; Bruinink DHO; Oliva S;

Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. in Blood / Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Griggio V; Vitale C; Coscia M; Salvetti C; Gaidano G; Mauro FR; Foà R; Boccadoro M; Scarfò L; Cuneo A; Tedeschi A; Reda G; Orsucci L; Trentin L; De Paoli L; Montalbano MC; Boccellato E; Perutelli F; Marchetti M; Pennese E; Gentile M; Rivela P; Murru R; Laurenti L; Rigolin GM; Vassallo F; Cassin R; Porrazzo M; Schiattone L; et alii...

Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2021 Jul 1;27(13):3695-3703. doi: 10.1158/1078-0432.CCR-21-0134. Epub 2021 Apr 29.

2021
AOU Città della Salute di Torino
AOU Novara

Gay F; Boccadoro M; Spencer A; Sonneveld P; Musto P; Hájek R; Gaidano G; Nagler A; Benevolo G; Belotti A; Patriarca F; Mina R; Cascavilla N; Ruggeri M; de Fabritiis P; Liberati AM; Mannina D; Capra A; Romano A; Corradini P; Offidani M; Petrucci MT; Zaccaria GM; Bertamini L;

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2021 Jan 1;106(1):291-294. doi: 10.3324/haematol.2019.241513.

2021
AOU Città della Salute di Torino

Bringhen S; Consoli U; Pitino A; Frigeri F; Tripepi G; Morabito F; Offidani M; Boccadoro M; Cavo M; Petrucci MT; Palmieri S; Di Raimondo F; De Stefano V; Patriarca F; Zamagni E; Recchia AG; Pompa A; Gamberi B; Gagliardi A; Gangemi D; Ballanti S; Martino M; Stocchi R; Siniscalchi A; Bonalumi A; Vincelli D; Fraticelli V; Vigna E; Curci P; et alii...

Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2021 Jan;21(1):e21-e24. doi: 10.1016/j.clml.2020.08.019. Epub 2020 Sep 1

2021
AOU Città della Salute di Torino

Boccadoro M; Zamagni E; Gay F; Bonello F; Mina R;

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. in Leukemia / Leukemia. 2021 Jan;35(1):31-44. doi: 10.1038/s41375-020-01016-0. Epub 2020 Aug 19.

2021
AOU Città della Salute di Torino

Sonneveld P; Bringhen S; Abildgaard N; Nijhof I; Beksac M; Leleu X; Goldschmidt H; van de Donk N; Engelhardt M; Garderet L; Jackson G; Weisel K; Einsele H; Delforge M; Caers J; Mateos MV; Mohty M; Zojer N; Terpos E; Avet-Loiseau H; Gay F; Dimopoulos MA; Hajek R; Driessen C; Facon T; Zweegman S; Pawlyn C; Cavo M; San-Miguel J; et alii...

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma. in Annals of hematology / Ann Hematol. 2021 Feb;100(2):437-443. doi: 10.1007/s00277-020-04384-w. Epub 2021 Jan 3.

2021
AOU Città della Salute di Torino
AOU Novara

Omedé P; Boccadoro M; Bringhen S; Genuardi E; Saraci E; Margiotta Casaluci G; Mina R; Gilestro M; D'Agostino M; Oddolo D; Troia R; Caltagirone S; Oliva S; De Paoli L; Ruggeri M;

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. in HemaSphere / Hemasphere. 2021 Feb 3;5(2):e528. doi: 10.1097/HS9.0000000000000528. eCollection 2021 Feb.

2021
AOU Città della Salute di Torino

Mey U; Sonneveld P; San-Miguel J; Boccadoro M; Einsele H; Facon T; Goldschmidt H; Schjesvold F; Cavo M; Hájek R; Delforge M; Cook G; Zweegman S; Mateos MV; Terpos E; Moreau P; Dimopoulos MA;

Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. in Blood cancer journal / Blood Cancer J. 2021 Dec 7;11(12):197. doi: 10.1038/s41408-021-00590-5.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara

Bonello F; Monaco F; Corradini P; Boccadoro M; Offidani M; Mina R; Ballanti S; De Sabbata G; Aquino S; De Paoli L; Grasso M; Cellini C; Paris L; Belotti A; Tacchetti P; Cea M; Zambello R; Musolino C; Patriarca F; Rota-Scalabrini D; Capra A; Pescosta N; Petrucci MT; Ciccone G; Bringhen S; Liberati AM; Falcone AP; Larocca A;

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1705-1720. doi: 10.1016/S1470-2045(21)00535-0. Epub 2021 Nov 11.

2021
AO Cuneo
AOU Città della Salute di Torino

Boccadoro M; Cavo M; Corradini P; Petrucci MT; Zambello R; Gamberi B; Aquino S; Palmas A; de Fabritiis P; Giuliani N; D'Agostino M; Capra A; Patriarca F; Cea M; Spadano A; Grasso M; Ballanti S; Zamagni E; Ledda A; Offidani M; Galli M; Belotti A; Bertamini L; Rota-Scalabrini D; Musto P; Gay F;

COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. in The Lancet. Haematology / Lancet Haematol. 2021 Dec;8(12):e934-e946. doi: 10.1016/S2352-3026(21)00278-7. Epub 2021 Oct 28.

2021
AOU Città della Salute di Torino

Terpos E; Boccadoro M; Schjesvold F; Broijl A; Kastritis E; Zojer N; Hajek R; Schreder M; Abildgaard N; Nijhof I; Beksac M; Goldschmidt H; Leleu X; van de Donk N; Garderet L; Jackson G; Weisel K; Caers J; Delforge M; Einsele H; Gay F; Cook G; Dimopoulos MA; Driessen C; Engelhardt M; Zweegman S; Pawlyn C; Cavo M; Moreau P; et alii...

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma. in Haematologica / Haematologica. 2021 Aug 1;106(8):2054-2065. doi: 10.3324/haematol.2020.276402.

2021
AOU Città della Salute di Torino

Boccadoro M; Sonneveld P; Einsele H; Terpos E; Dimopoulos MA; Popat R; Rodríguez-Lobato LG; Van de Donk NWCJ; Gagelmann N; Kröger N; Danhof S; D'Agostino M; Giaccone L; Gay F; Engelhardt M; Wäsch R; Bruno B;

Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):293-303. doi: 10.1002/hon.2864. Epub 2021 Mar 31.

2021
AOU Alessandria
AOU Città della Salute di Torino

Ferrero S; Ladetto M; Splinter E; Federico M; Boccadoro M; van Min M; Luminari S; Cortelazzo S; Vitolo U; Zaccaria GM; Yilmaz M; Lo Schirico M; Saraci E; Clerico M; Ragaini S; Grimaldi D; Dogliotti I; Alessandria B; Cavallo F; Drandi D; Ferrante M; Genuardi E; Klous P; Mantoan B;

Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? in Leukemia research / Leuk Res. 2021 Aug;107:106592. doi: 10.1016/j.leukres.2021.106592. Epub 2021 Apr 24.

2021
AOU Città della Salute di Torino

Boccadoro M; Gay F; Oliva S; Bonello F; Ferrero D;

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. in Blood cancer journal / Blood Cancer J. 2021 Apr 12;11(4):73. doi: 10.1038/s41408-021-00464-w.

2021
AOU San Luigi di Orbassano
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara

Bringhen S; Sonneveld P; Boccadoro M; Musto P; Hájek R; Corradini P; Guglielmelli T; Giuliani N; Aitoro G; Di Raimondo F; Bonello F; Benevolo G; Patriarca F; Innao V; de Fabritiis P; Zambello R; Cascavilla N; Liberati AM; Gaidano G; Petrucci MT; Derudas D; Capra A; Offidani M; Larocca A; D'Agostino M;

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies. in Haematologica / Haematologica. 2021 Apr 1;106(4):1079-1085. doi: 10.3324/haematol.2019.243428.

2021
AOU Città della Salute di Torino
AOU Novara

Bringhen S; Boccadoro M; Omedé P; Gaidano G; Palumbo A; Montefusco V; Cavo M; Siniscalchi A; Gilestro M; Galieni P; Capra A; Benevolo G; Olivieri A; Musto P; Ballanti S; Liberati AM; Conticello C; Petrucci MT; Bonello F; Mina R;

Targeting hif-1? regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll in Cancers

2021
AOU Città della Salute di Torino

Vitale C; Griggio V; Riganti C; Todaro M; Kopecka J; Jones R; Salvetti C; Boccellato E; Perutelli F; Voena C; Godio L; Boccadoro M; Coscia M;

Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2020 Sep 15;26(18):4832-4841. doi: 10.1158/1078-0432.CCR-20-0951. Epub 2020 Jul 2.

2020
AOU Città della Salute di Torino

D'Agostino M; Zaccaria GM; Ziccheddu B; Rustad EH; Genuardi E; Capra A; Oliva S; Auclair D; Yesil J; Colucci P; Keats JJ; Gambella M; Bringhen S; Larocca A; Boccadoro M; Bolli N; Maura F; Gay F;

New drugs in early development for treating multiple myeloma: all that glitters is not gold. in Expert opinion on investigational drugs / Expert Opin Investig Drugs. 2020 Sep;29(9):989-1004. doi: 10.1080/13543784.2020.1772753. Epub 2020 S

2020
AOU Città della Salute di Torino

Bertamini L; Bonello F; Boccadoro M; Bringhen S;

Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. in Annals of hematology / Ann Hematol. 2020 Sep;99(9):2197-2199. doi: 10.1007/s00277-020-04180-6. Epub 2020 Jul 13.

2020
AOU Città della Salute di Torino

Apolito V; Giaccone L; Ferrero S; Larocca A; Cavallo F; Coscia M; Beggiato E; Butera S; Martella F; Dainese C; Cetani G; Scaldaferri M; Cattel F; Boccadoro M; Ferrero D; Bruno B; Cerrano M;

Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients. in Cancers / Cancers (Basel). 2020 Oct 24;12(11):3106. doi: 10.3390/cancers12113106.

2020
AOU Città della Salute di Torino

Bonello F; Boccadoro M; Larocca A;

Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia. in British journal of haematology / Br J Haematol. 2020 Oct;191(1):e28-e32. doi: 10.1111/bjh.16960. Epub 2020 Jul 19.

2020
AO Cuneo
AOU Città della Salute di Torino

Bruno B; Ferrero D; Massaia M; Boccadoro M; Cattel F; Scaldaferri M; Faraci DG; Butera S; Martella F; Lia G; Olivi M; Cerrano M; Castella B; Giaccone L;

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True. in International journal of molecular sciences / Int J Mol Sci. 2020 Nov 1;21(21):8192. doi: 10.3390/ijms21218192.

2020
AOU Città della Salute di Torino

D'Agostino M; Innorcia S; Boccadoro M; Bringhen S;

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.

2020
ASL Biella
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Alessandria

Sonneveld P; Boccadoro M; Larocca A; Musto P; Romano A; Ria R; Giuliani N; Offidani M; Liberati AM; Marchetti M; Mosca-Siez ML; de Fabritiis P; Ballanti S; Monaco F; Gobbi M; Cellini C; Grasso M; Ronconi S; Pescosta N; Petrucci MT; Capra A; Zambello R; Mina R; Di Lullo G; Belotti A;

Extended half-life rFIX in major surgery-How to improve clinical practice: An intraindividual comparison. in Clinical case reports / Clin Case Rep. 2020 Feb 12;8(3):531-534. doi: 10.1002/ccr3.2450. eCollection 2020 Mar.

2020
AOU Città della Salute di Torino
AO Ordine Mauriziano

Boccadoro M; Borchiellini A; Montaruli B; Dosio E; Dainese C; Valpreda A; Agnelli Giacchello J; Valeri F;

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. in The Lancet. Haematology / Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.

2020
AOU Città della Salute di Torino
AO Cuneo

Sonneveld P; Boccadoro M; Carvalho S; Spencer A; Palmas A; Cafro AM; Minnema M; Mandigers C; van Marwijk Kooy M; Gimsing P; Mellqvist UH; Waage A; Driessen C; Specchia G; Zander T; Caravita di Toritto T; Durian M; von dem Borne PA; Hajek R; Wu KL; Boersma R; Morelli AM; Aquino S; Ludwig H; Levin MD; Bos G; Pascarella A; Benevolo G; Troia R; et alii...

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.

2020
ASL Torino 4
AOU Città della Salute di Torino
AO Cuneo

Boccadoro M; Larocca A; Hájek R; Falco P; Palumbo A; Cellini C; Marasca R; Gentile M; Baldini L; Tosi P; Petrucci MT; Santoro A; Poggiu M; Aquino S; Gazzera G; De Rosa L; Pavone V; Pescosta N; Pezzatti S; Grasso M; Rota-Scalabrini D; Spada S; Paris L; Ballanti S; Bringhen S; D'Agostino M;

Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. in Cancers / Cancers (Basel). 2020 Jan 23;12(2):282. doi: 10.3390/cancers12020282.

2020
AOU Città della Salute di Torino

Vitale C; Montalbano MC; Salvetti C; Boccellato E; Griggio V; Boccadoro M; Coscia M;

Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs. in Haematologica / Haematologica. 2020 Jan;105(1):193-200. doi: 10.3324/haematol.2019.219139. Epub 2019 Jun 20.

2020
AOU Città della Salute di Torino
AOU Novara

Corradini P; Cavo M; Offidani M; Liberati AM; Sonneveld P; Hajek R; Nagler A; Ben-Yehuda D; Cascavilla N; Nozzoli C; Ballanti S; Galieni P; Patriarca F; Musto P; Musolino C; Ribolla R; De Paoli L; Di Raimondo F; Spada S; Boccadoro M; Gay F; Montefusco V;

Droplet Digital PCR Assay for MYD88 (L265P) : Clinical Applications in Waldenström Macroglobulinemia. in HemaSphere / Hemasphere. 2020 Jan 3;4(1):e324. doi: 10.1097/HS9.0000000000000324. eCollection 2020 Feb.

2020
AOU Città della Salute di Torino
AOU Alessandria

Boccadoro M; Drandi D; Ferrero S; Ladetto M; Cavallo F; Omedè P; Benevolo G; Bertuzzo D; Ferrero B; Zamò A; Dogliotti I; Ferrante M; Lo Schirico M;

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 29;14(1):20. doi: 10.3390/ph14010020.

2020
AO Cuneo
AOU Città della Salute di Torino

Celeghini I; Castellino A; Boccadoro M; Bringhen S; Bonello F; Grasso M; D'Agostino M;

Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. J. Clin. Med. 2020, 9, 2142. in Journal of clinical medicine / J Clin Med. 2020 Aug 13;9(8):2630. doi: 10.3390/jcm9082630.

2020
AOU Città della Salute di Torino

Mina R; Oliva S; Boccadoro M;

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2020 Aug;34(8):2000-2011. doi: 10.1038/s41375-020-0876-z. Epub 2020 May 22.

2020
AOU Città della Salute di Torino

Terpos E; Engelhardt M; Cook G; Gay F; Mateos MV; Ntanasis-Stathopoulos I; van de Donk NWCJ; Avet-Loiseau H; Hajek R; Vangsted AJ; Ludwig H; Zweegman S; Moreau P; Einsele H; Boccadoro M; San Miguel J; Dimopoulos MA; Sonneveld P;

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents. in Blood cancer journal / Blood Cancer J. 2020 Apr 14;10(4):40. doi: 10.1038/s41408-020-0307-4.

2020
AOU Città della Salute di Torino
AOU Novara

Terpos E; Lonial S; De Paoli L; Jaye DL; Belotti A; Offidani M; Oliva S; Giuliani N; Roussou M; Omedé P; Boise LH; Patriarca F; Gavriatopoulou M; Montefusco V; Kaufman JL; Petrucci MT; Kastritis E; Gay F; Joseph NS; Mina R; Boccadoro M; Nooka AK; Dimopoulos MA;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Gattei V; Foà R; Massaia M; Gaidano G; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Magliulo D; Rossi D; Marchetti M; Bonello L; Pozzato G; Bo MD; Kopecka J; Bomben R; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V; Coscia M;

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials. in Haematologica / Haematologica. 2020 Apr;105(4):1074-1080. doi: 10.3324/haematol.2019.220657. Epub 2019 Jun 27.

2020
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Hájek R; Boccadoro M; Bringhen S; Palumbo A; De Paoli L; Romano A; Falcone AP; Zambello R; Giuliani N; Fraticelli V; Paris L; Amico V; Musto P; Innao V; Cangiolosi C; Bernardini A; Oddolo D; Benevolo G; Spada S; Patriarca F; Evangelista A; Liberati AM; Ledda A; Offidani M; Mina R; Larocca A;

Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma. in Frontiers in oncology / Front Oncol. 2020 Jan 31;10:1. doi: 10.3389/fonc.2020.00001. eCollection 2020.

2020
AOU Città della Salute di Torino

Oliva S; D'Agostino M; Boccadoro M; Larocca A;

Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia. in Frontiers in immunology / Front Immunol. 2020 Nov 18;11:594556. doi: 10.3389/fimmu.2020.594556. eCollection 2020.

2020
AOU Città della Salute di Torino

Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M;

CLL-220: Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib in Clinical Lymphoma, Myeloma and Leukemia

2020
AOU Città della Salute di Torino

Perutelli F; Griggio V; Vitale C; Mauro FR; Salvetti C; Boccellato E; Pietrasanta D; Vincelli ID; Ghia P; Del Poeta G; Gaidano G; Gattei V; Foà R; Boccadoro M; Coscia M;

Minimal residual disease in multiple myeloma: State of the art and future perspectives in Journal of Clinical Medicine

2020
AOU Città della Salute di Torino

Mina R; Oliva S; Boccadoro M;

Correlation between Plasmatic Extracellular Vesicles and Acute Graft Versus Host Disease after Post-Transplant Cyclophoshamide Haploidentical Stem Cell Transplantation in Haematologica

2020
AOU Città della Salute di Torino

Lia G; Di Vito C; Brunello L; Mariotti J; Bruno S; Santoro A; Bramanti S; Tapparo M; Zaghi E; Calvi M; Comba L; Fasci M; Giaccone L; Boccadoro M; Evangelista A; Camussi G; Castagna L; Mavilio D; Bruno B;

Immune Reconstitution and Clinical Outcomes in the Setting of HLA-Identical Allogeneic Hematopoietic Stem-Cell Transplantation in Haematologica

2020
AOU Città della Salute di Torino

Faraci DG; Lia G; Butera S; Evangelista A; Tosti L; Comba L; Cena S; Brunello L; Gilestro M; Ruggeri M; Oddolo D; Caltagirone SA; Muccio VE; Saraci E; Festuccia M; Ciccone G; Maffini E; Boccadoro M; Giaccone L; Omedè PM; Bruno B;

Droplet Digital PCR for Non-Invasive Mutational Screening in WaldenstrÃm Macroglobulinemia and IGM-MGUS: First Results of the Fondazione Italiana Linfomi (FIL) Bio-WM Trial in Haematologica

2020
ASL Asti
AOU Città della Salute di Torino

Cavallo F; Arcaini L; Boccadoro M; Garcia Sanz R; Varettoni M; Marcheselli L; Gilestro M; Picone C; Dogliotti I; Defrancesco I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Puig N; Rattotti S; Zibellini S; Candido C; Drandi D; Ferrero S; Ferrante M; et alii...

Characterization of B-Cell and Plasma Cell Compartment By Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial in Blood

2020
AOU Città della Salute di Torino

Varettoni M; Ferrero S; Picone C; Gilestro M; Puig N; Marcheselli L; Dogliotti I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Jiménez C; Zibellini S; Drandi D; Candido C; Ferrante M; Fabbri N; Cavallo F; Arcaini L; Boccadoro M; Garcia-Sanz R; et alii...

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes. in JCO clinical cancer informatics / JCO Clin Cancer Inform. 2019 Oct;3:1-15. doi: 10.1200/CCI.19.00049.

2019
AOU Città della Salute di Torino
AOU Alessandria

Balestra G; Omedè P; Zamò A; Ferreri A; Ballerini F; Molinari AL; Arcaini L; Lo Schirico M; Castagneri C; Barbero D; Sandrone R; Genuardi E; Evangelista A; Ghislieri M; Rosati S; Ferrero S; Zaccaria GM; Boccadoro M; Cortelazzo S; Ladetto M;

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis. in Cancers / Cancers (Basel). 2019 Nov 5;11(11):1735. doi: 10.3390/cancers11111735.

2019
AOU Città della Salute di Torino

Bonello F; Pulini S; Ballanti S; Gentile M; Spada S; Annibali O; Omedé P; Ronconi S; Cangialosi C; Podda L; Palmas A; Malfitano A; Rivoli G; Belotti A; Ciambelli F; Vincelli ID; Cafro AM; Innao V; Palumbo A; Sonneveld P; Spencer A; Hájek R; Boccadoro M; Gay F;

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis. in Cancer / Cancer. 2019 Mar 1;125(5):750-760. doi: 10.1002/cncr.31854. Epub 2018 Dec 18.

2019
AOU Città della Salute di Torino

Gambella M; Omedé P; Spada S; Muccio VE; Gilestro M; Saraci E; Grammatico S; Larocca A; Conticello C; Bernardini A; Gamberi B; Troia R; Liberati AM; Offidani M; Rocci A; Palumbo A; Cavo M; Sonneveld P; Boccadoro M; Oliva S;

Adoptive immunotherapy with CAR modified T cells in cancer: current landscape and future perspectives. in Frontiers in bioscience (Landmark edition) / Front Biosci (Landmark Ed). 2019 Jun 1;24:1284-1315.

2019
AOU Città della Salute di Torino

Coscia M; Vitale C; Cerrano M; Maffini E; Giaccone L; Boccadoro M; Bruno B;

Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma. in Current hematologic malignancy reports / Curr Hematol Malig Rep. 2019 Jun;14(3):187-196. doi: 10.1007/s11899-019-00507-x.

2019
AOU Città della Salute di Torino

Offidani M; Boccadoro M; Di Raimondo F; Petrucci MT; Tosi P; Cavo M;

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. in Journal of internal medicine / J Intern Med. 2019 Jul;286(1):63-74. doi: 10.1111/joim.12882. Epub 2019 Apr 8.

2019
AOU Città della Salute di Torino

Bringhen S; Milan A; D'Agostino M; Ferri C; Wäsch R; Gay F; Larocca A; Offidani M; Zweegman S; Terpos E; Goldschmidt H; Cavo M; Ludwig H; Driessen C; Auner HW; Caers J; Gramatzki M; Dimopoulos MA; Boccadoro M; Einsele H; Sonneveld P; Engelhardt M;

Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial. in Journal of hematology & oncology / J Hematol Oncol. 2019 Jan 9;12(1):4. doi: 10.1186/s13045-018-0691-4.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Ria R; Vacca A; Dammacco F; Boccadoro M; Petrucci MT; Musto P; Montefusco V; Rizzo M; Gottardi D; Falcone AP; Grasso M; Leonardi G; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Patriarca F; Martino E; Larocca A; Offidani M; De Paoli L; Bringhen S; Palumbo A; Omedè P; Terragna C; Giuliani N; Morabito F; Saltarella I; et alii...

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study). in Annals of hematology / Ann Hematol. 2019 Feb;98(2):361-367. doi: 10.1007/s00277-018-3524-1. Epub 2018 Oct 23.

2019
AOU Città della Salute di Torino

Musto P; Simeon V; Cascavilla N; Falcone A; Petrucci MT; Cesini L; Di Raimondo F; Conticello C; Ria R; Catalano L; Salvatore D; Mastrullo L; Gagliardi A; Villani O; Pietrantuono G; D'Arena G; Mansueto G; Bringhen S; Genuardi M; Di Renzo N; Reddiconto G; Fragasso A; Caravita T; Scapicchio D; Marziano G; Boccadoro M; Mangiacavalli S; Corso A;

Insights on Multiple Myeloma Treatment Strategies. in HemaSphere / Hemasphere. 2018 Dec 27;3(1):e163. doi: 10.1097/HS9.0000000000000163. eCollection 2019 Feb.

2019
AOU Città della Salute di Torino

Mateos MV; Ludwig H; Bazarbachi A; Beksac M; Bladé J; Boccadoro M; Cavo M; Delforge M; Dimopoulos MA; Facon T; Geraldes C; Goldschmidt H; Hájek R; Hansson M; Jamroziak K; Leiba M; Masszi T; Mendeleeva L; O'Dwyer M; Plesner T; San-Miguel JF; Straka C; van de Donk NWCJ; Yong K; Zver S; Moreau P; Sonneveld P;

Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma. in Cancers / Cancers (Basel). 2019 Dec 19;12(1):15. doi: 10.3390/cancers12010015.

2019
AOU Città della Salute di Torino

Bonello F; Mina R; Boccadoro M; Gay F;

Pursuing a Curative Approach in Multiple Myeloma: A Review of New Therapeutic Strategies. in Cancers / Cancers (Basel). 2019 Dec 13;11(12):2015. doi: 10.3390/cancers11122015.

2019
AOU Città della Salute di Torino

D'Agostino M; Bertamini L; Oliva S; Boccadoro M; Gay F;

FLAI induction regimen in elderly patients with acute myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2019 Dec;60(13):3339-3340. doi: 10.1080/10428194.2019.1620943. Epub 2019 Jun 4.

2019
AOU Città della Salute di Torino

Bruno B; Audisio E; Boccadoro M; Zannier ME; D'Ardia S; Dubbini MV; Crisà E; Candoni A; Cerrano M; Ferrero D;

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies. in Haematologica / Haematologica. 2019 Aug;104(8):1640-1647. doi: 10.3324/haematol.2018.208272. Epub 2019 Feb 7.

2019
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Di Raimondo F; Montefusco V; Di Toritto TC; Cavo M; Galieni P; Ponticelli E; Benevolo G; Spada S; Offidani M; Musto P; Ballanti S; Gaidano G; Petrucci MT; Mina R; Bringhen S; Boccadoro M; Larocca A;

Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma. in Current medicinal chemistry / Curr Med Chem. 2019;26(32):5968-5981. doi: 10.2174/0929867325666180514114806.

2019
AOU Città della Salute di Torino

D'Agostino M; Gazzera G; Cetani G; Bringhen S; Boccadoro M; Gay F;

Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study in Blood

2019
AOU Città della Salute di Torino

Hungria VTM; Lee HC; Abonour R; Rifkin RM; Terpos E; Leleu X; Costello CL; van Rhee F; Weisel KC; Puig N; Berdeja JG; Cook G; Usmani SZ; Thompson MA; Boccadoro M; Zonder JA; Spencer A; Hajek R; Fanning SR; Boyd K; Omel J; Armour M; Morgan KE; Patel RS; Carlson GL; Ferrari RH; Stull DM; Ren K; Cherepanov D; et alii...

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide in Blood

2019
AOU Città della Salute di Torino

Lia G; Di Vito C; Tapparo M; Bruno S; Zaghi E; Calvi M; Brunello L; Mariotti J; Comba L; Giaccone L; Fascì M; Boccadoro M; Evangelista A; Castagna L; Camussi G; Mavilio D; Bruno B;

Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs in Blood

2019
ASL Asti
AOU Città della Salute di Torino

Vitale C; Salvetti C; Griggio V; Scamuffa MC; Zamprogna G; Visentin A; Cassin R; Laurenti L; Murru R; Rivela P; Marchetti M; Gentile M; Pennese E; Reda G; Trentin L; Tedeschi A; Mauro FR; Foà R; Boccadoro M; Coscia M;

Carfilzomib, bendamustine, dexamethasone in patients with advanced multiple myeloma: The EMN09 Phase I/II study of the European Myeloma Network in Clinical Lymphoma, Myeloma and Leukemia

2019
AOU Città della Salute di Torino

Gramatzki M; Offidani M; Günther A; Engelhardt M; Salvini M; Montefusco V; Patriarca F; Angelucci E; Poenisch W; Spada S; Schub N; Gentili S; Wäsch R; Corradini P; Einsele H; Boccadoro M; Sonneveld P; Gay F;

A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy in Clinical Lymphoma, Myeloma and Leukemia

2019
AOU Città della Salute di Torino

Weisel K; Hungria V; Leleu X; Lee H; Rifkin R; Costello C; Abonour R; Chari A; Puig N; Berdeja J; Cook G; Thompson MA; Boccadoro M; Terpos E; Zonder JA; Vela-Ojeda J; Davies F; van Rhee F; Hajek R; Spencer A; Omel J; Armour M; Stull DM; Carlson G; Elliott J; Cherepanov D; Ferrari R; Skacel T; Ren K; et alii...

Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study in Clinical Lymphoma, Myeloma and Leukemia

2019
AOU Città della Salute di Torino

D'Agostino M; Zaccaria GM; Ziccheddu B; Genuardi E; Maura F; Oliva S; Auclair D; Yesil J; Capra A; Colucci P; Poggiu M; Keats J; Larocca A; Gambella M; Bolli N; Boccadoro M; Gay F;

Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells in Clinical Lymphoma, Myeloma and Leukemia

2019
AOU Città della Salute di Torino

Vitale C; Todaro M; Griggio V; Salvetti C; Riganti C; Landesman Y; Boccadoro M; Coscia M;

Long-Term Thymic Function and Reconstitution of the T Cell Compartment after T Cell-Replete Haplo-Identical Allografting in Biology of Blood and Marrow Transplantation

2019
AOU Città della Salute di Torino

Lia G; Butera S; Evangelista A; Tosti L; Comba L; Cena S; Brunello L; Gilestro M; Ruggeri M; Oddolo D; Caltagirone SA; Muccio VE; Saraci E; Festuccia M; Ciccone G; Maffini E; Boccadoro M; Giaccone L; Omede P; Bruno B;

Biomarkers of Acute Graft-Versus-Host Disease: Surface Antigens and Micro Rnas in Extracellular Vesicles in Biology of Blood and Marrow Transplantation

2019
AOU Città della Salute di Torino

Brunello L; Lia G; Bruno S; Tapparo M; Omede P; Festuccia M; Maffini E; Ciccone G; Comba L; Tosti L; Giaccone L; Boccadoro M; Evangelista A; Camussi G; Bruno B;

Ixazomib plus lenalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: A pooled analysis from the insight mm observational study and the Czech registry of monoclonal gammopathies in British Journal of Haematology

2019
AOU Città della Salute di Torino

Cook G; Hájek R; Terpos E; Lee HC; Chari A; Costello CL; Puig N; Leleu X; Berdeja JG; Davies FE; Weisel KC; Usmani SZ; Hungria VTM; Boccadoro M; Rifkin RM; Zonder JA; Brožová L; Ren K; Cacioppo R; Skacel T; Stull DM; Maisnar V;

Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia in Blood

2019
AOU Città della Salute di Torino

Griggio V; Vitale C; Salvetti C; Mauro FR; Pietrasanta D; Vincelli ID; Scarfo L; Del Poeta G; Gaidano G; Gattei V; Foà R; Boccadoro M; Coscia M;

The Locommotion Study (MMY4001): A Prospective, Multinational Study of Real-Life Current Standards of Care in Patients with Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including PI, IMiD, and CD38 Monoclonal Antibody Treatment and Documented Disease Progression in Blood

2019
AOU Città della Salute di Torino

Delforge M; Moreau P; Mateos M-V; De Stefano V; Weisel K; San-Miguel J; Einsele H; Facon T; Boccadoro M; Goldschmidt H; Cavo M; Rosinol L; Kaiser MF; Gay F; Scheid C; Broyl A; Van De Donk NWCJ; Rodriguez P; Potamianou A; Sakabedoyan C; Strulev V; Nesheiwat T; Bergmans P; Rizvi S; Pilatowicz A; Sonneveld P;

Tumor Circulating Plasma Cells Detected By Flow Cytometric Single Platform Method Correlate with Clinical Response to Therapy and Unfavorable Patients' Characteristics in Blood

2019
AOU Città della Salute di Torino

Muccio VE; Gilestro M; Saraci E; Capra A; Costa A; Ruggeri M; Caltagirone S; Oddolo D; Mussatto C; Musto P; Pantani L; Pavone V; Ronconi S; Vincelli ID; Cafro AM; Cellini C; Innao V; Piro E; Gay F; Boccadoro M; Omedé P;

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

2018
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Beggiato E; Pugliese N; Elli EM; Martinelli V; Palumbo GA; Cilloni D; Ferrero D; Crisà E;

Determining treatment intensity in elderly patients with multiple myeloma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Sep;18(9):917-930. doi: 10.1080/14737140.2018.1496823. Epub 2018 Ju

2018
AOU Città della Salute di Torino

Salvini M; D'Agostino M; Bonello F; Boccadoro M; Bringhen S;

Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA). in Haematologica / Haematologica. 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26.

2018
AOU Città della Salute di Torino

Bringhen S; Milan A; Ferri C; Wäsch R; Gay F; Larocca A; Salvini M; Terpos E; Goldschmidt H; Cavo M; Petrucci MT; Ludwig H; Auner HW; Caers J; Gramatzki M; Boccadoro M; Einsele H; Sonneveld P; Engelhardt M;

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis. in JAMA oncology / JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

2018
AOU Città della Salute di Torino

Gay F; Jackson G; Rosiñol L; Holstein SA; Moreau P; Spada S; Davies F; Lahuerta JJ; Leleu X; Bringhen S; Evangelista A; Hulin C; Panzani U; Cairns DA; Di Raimondo F; Macro M; Liberati AM; Pawlyn C; Offidani M; Spencer A; Hájek R; Terpos E; Morgan GJ; Bladé J; Sonneveld P; San-Miguel J; McCarthy PL; Ludwig H; Boccadoro M; et alii...

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e401-e419. doi: 10.1016/j.clml.2018.06.018. Epub 2018 Ju

2018
AOU Città della Salute di Torino

Mohty M; Terpos E; Mateos MV; Cavo M; Lejniece S; Beksac M; Bekadja MA; Legiec W; Dimopoulos M; Stankovic S; Durán MS; De Stefano V; Corso A; Kochkareva Y; Laane E; Berthou C; Salwender H; Masliak Z; Willenbacher W; Silva J; Louw V; Nemet D; Borbényi Z; Abadi U; Pedersen RS; Potamianou A; Couturier C; Feys C; Thoret-Bauchet F; et alii...

Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Oct;130:27-35. doi: 10.1016/j.critrevonc.2018.07.003. Epub 2018 Jul 18.

2018
AOU Città della Salute di Torino
AOU Alessandria

Palumbo A; Meneghini V; Siniscalchi A; De Stefano V; Rocco S; Andriani A; Baraldi A; Ferrando P; Angelucci E; Annibali O; Palmas A; Aitini E; Centurioni R; Bernardini A; Storti S; Vallone R; Marcatti M; Musto P; Di Renzo N; Evangelista A; Larocca A; Grammatico S; Boccadoro M; Rizzi R; Spada S; Pisani F; Offidani M; Palmieri S; Bringhen S; et alii...

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. in Haematologica / Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31.

2018
AOU Città della Salute di Torino

Caers J; Garderet L; Kortüm KM; O'Dwyer ME; van de Donk NWCJ; Binder M; Dold SM; Gay F; Corre J; Beguin Y; Ludwig H; Larocca A; Driessen C; Dimopoulos MA; Boccadoro M; Gramatzki M; Zweegman S; Einsele H; Cavo M; Goldschmidt H; Sonneveld P; Delforge M; Auner HW; Terpos E; Engelhardt M;

Extracellular vesicles as potential biomarkers of acute graft-vs-host disease. in Leukemia / Leukemia. 2018 Mar;32(3):765-773. doi: 10.1038/leu.2017.277. Epub 2017 Aug 30.

2018
AOU Città della Salute di Torino

Lia G; Brunello L; Bruno S; Carpanetto A; Omedè P; Festuccia M; Tosti L; Maffini E; Giaccone L; Arpinati M; Ciccone G; Boccadoro M; Evangelista A; Camussi G; Bruno B;

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia. in European journal of haematology / Eur J Haematol. 2018 Mar;100(3):304-307. doi: 10.1111/ejh.13014. Epub 2018 Jan 15.

2018
AOU Città della Salute di Torino

Borchiellini A; Boccadoro M; Valeri F; Agnelli Giacchello J;

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol. in Health and quality of life outcomes / Health Qual Life Outcomes. 2018 Jun 18;16(1):127. doi: 10.1186/s12955-018-0953-4.

2018
AOU Città della Salute di Torino

Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M;

Highly sensitive MYD88(L265P) mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia. in Haematologica / Haematologica. 2018 Jun;103(6):1029-1037. doi: 10.3324/haematol.2017.186528. Epub 2018 Mar 22.

2018
AOU Città della Salute di Torino
AOU Alessandria

Ferrero S; Ladetto M; Boccadoro M; Sanz RG; Galimberti S; Cavallo F; Benevolo G; Orsucci L; Passera R; Omedè P; Zaccaria GM; Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G;

Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients. in British journal of haematology / Br J Haematol. 2018 Jul;182(2):165-167. doi: 10.1111/bjh.15260. Epub 2018 May 6.

2018
AOU Città della Salute di Torino

Larocca A; D'Agostino M; Boccadoro M;

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19

2018
AOU Città della Salute di Torino
AOU Novara

Corradini P; Tacchetti P; Musto P; Nagler A; Ria R; Caravita T; Benevolo G; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Rizzi R; Cascavilla N; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Patriarca F; Crippa C; Spada S; De Paoli L; Di Raimondo F; Cerrato C; Offidani M; Palumbo A; Petrucci MT; et alii...

Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. in Leukemia / Leukemia. 2018 Jul;32(7):1542-1560. doi: 10.1038/s41375-018-0040-1. Epub 2018 May 2.

2018
AOU Città della Salute di Torino

Ludwig H; Delforge M; Facon T; Einsele H; Gay F; Moreau P; Avet-Loiseau H; Boccadoro M; Hajek R; Mohty M; Cavo M; Dimopoulos MA; San-Miguel JF; Terpos E; Zweegman S; Garderet L; Mateos MV; Cook G; Leleu X; Goldschmidt H; Jackson G; Kaiser M; Weisel K; van de Donk NWCJ; Waage A; Beksac M; Mellqvist UH; Engelhardt M; Caers J; et alii...

Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma. in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation / Biol Blood Marrow Transplant. 2018 Jan;24(1):189-193. doi: 10.1016/j.bbmt.2017.09.017. Epub 2017 Oct

2018
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria

Fanin R; Ciccone G; Boccadoro M; Bruno B; Mordini N; Bringhen S; Maffini E; Omedé P; Zallio F; Festuccia M; Brunello L; Pini M; Carnevale-Schianca F; Sorasio R; Evangelista A; Patriarca F; Giaccone L;

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives. in Haematologica / Haematologica. 2018 Feb;103(2):197-211. doi: 10.3324/haematol.2017.174573. Epub 2017 Dec 7.

2018
AOU Città della Salute di Torino

Gay F; Engelhardt M; Terpos E; Wäsch R; Giaccone L; Auner HW; Caers J; Gramatzki M; van de Donk N; Oliva S; Zamagni E; Garderet L; Straka C; Hajek R; Ludwig H; Einsele H; Dimopoulos M; Boccadoro M; Kröger N; Cavo M; Goldschmidt H; Bruno B; Sonneveld P;

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M; Nagler A; Boccadoro M; Gay F;

CD38 as an immunotherapeutic target in multiple myeloma. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2018 Dec;18(12):1209-1221. doi: 10.1080/14712598.2018.1544240. Epub 2018 Nov

2018
AOU Città della Salute di Torino

Bonello F; D'Agostino M; Moscvin M; Cerrato C; Boccadoro M; Gay F;

A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma. in British journal of haematology / Br J Haematol. 2018 Dec;183(5):828-831. doi: 10.1111/bjh.15057. Epub 2017 Dec 19.

2018
AOU Città della Salute di Torino

Ghione P; Cavallo F; Visco C; Chen Z; Castellino A; Tisi MC; Dogliotti I; Nicolosi M; Boccadoro M; Leonard JP; Vitolo U; Martin P;

Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):533-540. doi: 10.1016/j.clml.2018.05.019. Epub 2018 May 2

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Hájek R; Calafiore V; Nagler A; Palumbo A; Falcone AP; Zambello R; Benevolo G; Mannina D; Guglielmelli T; Gamberi B; Baldini L; Musto P; Malfitano A; Ria R; Pescosta N; De Paoli L; Cerrato C; Patriarca F; Spada S; Corradini P; Mina R; Petrucci MT; Spencer A; Boccadoro M; Bringhen S;

A look at treatment strategies for relapsed multiple myeloma. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Aug;18(8):735-750. doi: 10.1080/14737140.2018.1477594. Epub 2018 Ma

2018
AOU Città della Salute di Torino

Cetani G; Boccadoro M; Oliva S;

Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN). in Leukemia / Leukemia. 2018 Aug;32(8):1697-1712. doi: 10.1038/s41375-018-0142-9. Epub 2018 Apr 25.

2018
AOU Città della Salute di Torino

Larocca A; Dold SM; Zweegman S; Terpos E; Wäsch R; D'Agostino M; Scheubeck S; Goldschmidt H; Gay F; Cavo M; Ludwig H; Straka C; Bringhen S; Auner HW; Caers J; Gramatzki M; Offidani M; Dimopoulos MA; Einsele H; Boccadoro M; Sonneveld P; Engelhardt M;

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study. in Leukemia / Leukemia. 2018 Aug;32(8):1803-1807. doi: 10.1038/s41375-018-0024-1. Epub 2018 Jan 30.

2018
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Lombardo A; Bertazzoni P; Rossi G; De Paoli L; Fanin R; Troia R; Patriarca F; Gaidano G; Belotti A; Spada S; Liberati AM; Cafro AM; Mina R; Bringhen S; Sonneveld P; Boccadoro M;

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. in Leukemia / Leukemia. 2018 Apr;32(4):979-985. doi: 10.1038/leu.2017.327. Epub 2017 Nov 16.

2018
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Corradini P; Gaidano G; Petrucci MT; Offidani M; Ballanti S; De Angelis C; Musto P; Esma F; Muccio VE; Grammatico S; Liberati AM; Galieni P; Montefusco V; De Paoli L; D'Agostino M; Bringhen S; Sonneveld P; Boccadoro M;

Relevance of sample preparation for flow cytometry. in International journal of laboratory hematology / Int J Lab Hematol. 2018 Apr;40(2):152-158. doi: 10.1111/ijlh.12755. Epub 2017 Oct 6.

2018
AOU Città della Salute di Torino

Muccio VE; Saraci E; Gilestro M; Oddolo D; Ruggeri M; Caltagirone S; Bruno B; Boccadoro M; Omedè P;

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma. in Frontiers in immunology / Front Immunol. 2018 Nov 27;9:2749. doi: 10.3389/fimmu.2018.02749. eCollection 2018.

2018
AOU Città della Salute di Torino

Oliva S; Troia R; D'Agostino M; Boccadoro M; Gay F;

Comparison of recovery coeffcient in different reconstruction algorithm in state-of-the-art non digital PET/CT scanners in European Journal of Nuclear Medicine and Molecular Imaging

2018
AOU Città della Salute di Torino

Chauvie S; Bergesio F; Chiesa C; De Ponti E; Morzenti S; Ragazzoni M; Matheoud R; Nanni C; Zamagni E; Versari A; Tacchetti P; Pantani L; Bianchi A; Rensi M; Bellò M; Gallamini A; Patriarca F; Bertone E; Zannetti B; Boccadoro M; Cavo M; Fanti S;

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study in Clinical Lymphoma, Myeloma and Leukemia

2018
AOU Città della Salute di Torino

Costello C; Boccadoro M; Usmani SZ; Chari A; Rifkin RM; Abonour R; Berdeja J; Cook G; Goldschmidt H; Hajek R; Hungria V; Lee HC; Leleu X; Omel J; Spencer A; Thompson MA; Vela-Ojeda J; Zonder JA; Puig N; Aguarón A; Davies FE; Demers B; Ren K; Yu S; Skacel T; Stull DM; Terpos E;

Regulation of HIF-1 ? in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target in Clinical Lymphoma, Myeloma and Leukemia

2018
AOU Città della Salute di Torino

Vitale C; Griggio V; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Rossi D; Pozzato G; Marchetti M; Omedè P; Bonello L; Kodipad AA; Laurenti L; Del Poeta G; Mauro FR; Bernardi R; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;

Promising Role of Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease in Biology of Blood and Marrow Transplantation

2018
AOU Città della Salute di Torino

Lia G; Bruno S; Brunello L; Omedè P; Tosti L; Giaccone L; Arpinati M; Boccadoro M; Evangelista A; Camussi G; Bruno B;

Induction of structural and functional effects of myeloma cells after Daratumumab treatment in Journal of Extracellular Vesicles

2018
AOU Città della Salute di Torino

Yakymiv Y; Faini AC; Castella B; Horenstein AL; Bracci C; Morandi F; Larocca A; Oliva S; Massaia M; Boccadoro M; Malavasi F;

Emerging drugs and combinations to treat multiple myeloma. in Oncotarget / Oncotarget. 2017 Jul 15;8(36):60656-60672. doi: 10.18632/oncotarget.19269. eCollection 2017 Sep 1.